Spil
FDA Approved Drugs

Spil

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX Discontinued
  • Total Records 11
  • Latest Approval Date Feb 28, 2022
  • Data Source FDA
  • First Approval Date Jan 26, 2018
All
11
View
Discontinued
6
View
RX
5
View
Company Overview

Company

Spil

Country

Taiwan

Website

Visit Website

Email

info@spil.com.tw

Social Profiles

Company Snapshot

Spil

No. 123, Sec. 3, Da Fong Rd., Tantzu, Taichung 427

Taiwan

www.spil.com.tw/ info@spil.com.tw View on Map
FDA Approved Drug Records ( 11 records )
2021
14 Dec
RX Application: 212514

Drug Name

AMPHOTERICIN B

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2021-12-14

212514 / 1

Active Ingredient

AMPHOTERICIN B

Application Number

212514

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2021-12-14

Regulatory Status

RX

2022
28 Feb
Discontinued Application: 216018

Drug Name

ASPRUZYO SPRINKLE

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2022-02-28

216018 / 1

Active Ingredient

RANOLAZINE

Application Number

216018

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2022-02-28

Regulatory Status

Discontinued

2022
28 Feb
Discontinued Application: 216018

Drug Name

ASPRUZYO SPRINKLE

Product Number

2

Dosage Form

-

Strength

1GM

Approval Date

2022-02-28

216018 / 2

Active Ingredient

RANOLAZINE

Application Number

216018

Product Number

2

Dosage Form

-

Strength

1GM

Approval Date

2022-02-28

Regulatory Status

Discontinued

2018
26 Jan
RX Application: 210428

Drug Name

KAPSPARGO SPRINKLE

Product Number

1

Dosage Form

-

Strength

EQ 25MG TARTRATE

Approval Date

2018-01-26

210428 / 1

Active Ingredient

METOPROLOL SUCCINATE

Application Number

210428

Product Number

1

Dosage Form

-

Strength

EQ 25MG TARTRATE

Approval Date

2018-01-26

Regulatory Status

RX

2018
26 Jan
RX Application: 210428

Drug Name

KAPSPARGO SPRINKLE

Product Number

2

Dosage Form

-

Strength

EQ 50MG TARTRATE

Approval Date

2018-01-26

210428 / 2

Active Ingredient

METOPROLOL SUCCINATE

Application Number

210428

Product Number

2

Dosage Form

-

Strength

EQ 50MG TARTRATE

Approval Date

2018-01-26

Regulatory Status

RX

2018
26 Jan
RX Application: 210428

Drug Name

KAPSPARGO SPRINKLE

Product Number

3

Dosage Form

-

Strength

EQ 100MG TARTRATE

Approval Date

2018-01-26

210428 / 3

Active Ingredient

METOPROLOL SUCCINATE

Application Number

210428

Product Number

3

Dosage Form

-

Strength

EQ 100MG TARTRATE

Approval Date

2018-01-26

Regulatory Status

RX

2018
26 Jan
RX Application: 210428

Drug Name

KAPSPARGO SPRINKLE

Product Number

4

Dosage Form

-

Strength

EQ 200MG TARTRATE

Approval Date

2018-01-26

210428 / 4

Active Ingredient

METOPROLOL SUCCINATE

Application Number

210428

Product Number

4

Dosage Form

-

Strength

EQ 200MG TARTRATE

Approval Date

2018-01-26

Regulatory Status

RX

2019
16 Apr
Discontinued Application: 210838

Drug Name

NIFEDIPINE

Product Number

1

Dosage Form

-

Strength

30MG

Approval Date

2019-04-16

210838 / 1

Active Ingredient

NIFEDIPINE

Application Number

210838

Product Number

1

Dosage Form

-

Strength

30MG

Approval Date

2019-04-16

Regulatory Status

Discontinued

2019
16 Apr
Discontinued Application: 210838

Drug Name

NIFEDIPINE

Product Number

2

Dosage Form

-

Strength

60MG

Approval Date

2019-04-16

210838 / 2

Active Ingredient

NIFEDIPINE

Application Number

210838

Product Number

2

Dosage Form

-

Strength

60MG

Approval Date

2019-04-16

Regulatory Status

Discontinued

2019
16 Apr
Discontinued Application: 210838

Drug Name

NIFEDIPINE

Product Number

3

Dosage Form

-

Strength

90MG

Approval Date

2019-04-16

210838 / 3

Active Ingredient

NIFEDIPINE

Application Number

210838

Product Number

3

Dosage Form

-

Strength

90MG

Approval Date

2019-04-16

Regulatory Status

Discontinued

2018
20 Jul
Discontinued Application: 210593

Drug Name

OMEPRAZOLE MAGNESIUM

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2018-07-20

210593 / 1

Active Ingredient

OMEPRAZOLE MAGNESIUM

Application Number

210593

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2018-07-20

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    11 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
11 total
  • RX
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

AMPHOTERICIN B

Application Number

212514

Product Number

1

Active Ingredient

AMPHOTERICIN B

Dosage Form

-

Strength

50MG/VIAL

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit